- Home
- PTGX vs DKL Comparison
PTGX vs DKL Comparison
Compare PTGX & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- DKL
- Stock Information
- Founded
- PTGX 2006
- DKL 2012
- Country
- PTGX United States
- DKL United States
- Employees
- PTGX N/A
- DKL N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- DKL Natural Gas Distribution
- Sector
- PTGX Health Care
- DKL Energy
- Exchange
- PTGX Nasdaq
- DKL Nasdaq
- Market Cap
- PTGX 3.3B
- DKL 2.3B
- IPO Year
- PTGX 2016
- DKL N/A
- Fundamental
- Price
- PTGX $53.00
- DKL $44.11
- Analyst Decision
- PTGX Strong Buy
- DKL Buy
- Analyst Count
- PTGX 9
- DKL 4
- Target Price
- PTGX $67.11
- DKL $44.25
- AVG Volume (30 Days)
- PTGX 923.4K
- DKL 89.4K
- Earning Date
- PTGX 08-05-2025
- DKL 08-05-2025
- Dividend Yield
- PTGX N/A
- DKL 10.00%
- EPS Growth
- PTGX N/A
- DKL 7.97
- EPS
- PTGX 0.86
- DKL 2.98
- Revenue
- PTGX $207,801,000.00
- DKL $938,491,000.00
- Revenue This Year
- PTGX N/A
- DKL $21.19
- Revenue Next Year
- PTGX $53.09
- DKL N/A
- P/E Ratio
- PTGX $61.48
- DKL $14.90
- Revenue Growth
- PTGX N/A
- DKL N/A
- 52 Week Low
- PTGX $32.50
- DKL $34.59
- 52 Week High
- PTGX $60.60
- DKL $45.71
- Technical
- Relative Strength Index (RSI)
- PTGX 53.99
- DKL 61.10
- Support Level
- PTGX $49.38
- DKL $43.63
- Resistance Level
- PTGX $51.51
- DKL $44.64
- Average True Range (ATR)
- PTGX 2.02
- DKL 0.85
- MACD
- PTGX -0.39
- DKL 0.03
- Stochastic Oscillator
- PTGX 46.09
- DKL 79.92
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.